Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Saved in:
| Title: | Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). |
|---|---|
| Authors: | Chioncel, Ovidiu1,2 (AUTHOR) ochioncel@yahoo.co.uk, Mebazaa, Alexandre3 (AUTHOR), Farmakis, Dimitrios4 (AUTHOR), Abdelhamid, Magdy5 (AUTHOR), Lund, Lars H.6 (AUTHOR), Harjola, Veli‐Pekka7 (AUTHOR), Anker, Stefan8,9,10 (AUTHOR), Filippatos, Gerasimos4 (AUTHOR), Ben‐Gal, Tuvia11 (AUTHOR), Damman, Kevin12 (AUTHOR), Skouri, Hadi13,14 (AUTHOR), Antohi, Laura1,2 (AUTHOR), Collins, Sean P.15 (AUTHOR), Adamo, Marianna16 (AUTHOR), Miro, Oscar17 (AUTHOR), Hill, Loreena18 (AUTHOR), Parissis, John4 (AUTHOR), Moura, Brenda19,20 (AUTHOR), Mueller, Christian21 (AUTHOR), Jankowska, Ewa22,23 (AUTHOR) |
| Source: | European Journal of Heart Failure. Jun2025, Vol. 27 Issue 6, p1067-1088. 22p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13889842 |
|---|---|
| DOI: | 10.1002/ejhf.3673 |
